Tango Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Tango Therapeutics, Inc. (TNGX) reported Increase (Decrease) in Other Noncurrent Assets of $9.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-11
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $19.00K, a 93.81% decline year-over-year.
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$10.00K.
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $13.00K.
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$20.00K, a 1100.00% decline year-over-year.
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $299.00K.
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$43.00K, a 204.88% decline from fiscal 2023.
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $41.00K.
- Tango Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$122.00K, a 187.77% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $9.00K 10-Q · filed 2026-08-11 | $22.00K derived: sum of 3 quarters · filed 2026-08-11 | $2.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-13 | $3.00K derived: sum of 2 quarters · filed 2026-05-13 | -$17.00K derived: sum of 3 quarters · filed 2026-05-13 | $290.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$7.00K derived: sum of 2 quarters · filed 2026-03-05 | $300.00K derived: sum of 3 quarters · filed 2026-08-11 | $299.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $287.00K derived: sum of 2 quarters · filed 2026-08-11 | $286.00K 10-Q · filed 2025-11-04 | $277.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $307.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $306.00K 10-Q · filed 2026-08-11 | $297.00K derived: sum of 3 quarters · filed 2026-08-11 | $299.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$1.00K 10-Q · filed 2026-05-13 | -$10.00K derived: sum of 2 quarters · filed 2026-05-13 | -$8.00K derived: sum of 3 quarters · filed 2026-05-13 | -$9.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$7.00K derived: sum of 2 quarters · filed 2026-03-05 | -$8.00K derived: sum of 3 quarters · filed 2026-03-05 | -$43.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.00K derived: sum of 2 quarters · filed 2025-11-04 | -$34.00K 10-Q · filed 2025-11-04 | -$35.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$36.00K 10-Q · filed 2025-08-05 | -$37.00K derived: sum of 3 quarters · filed 2026-03-05 | -$2.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | -$35.00K 10-Q · filed 2025-05-12 | -$36.00K derived: sum of 2 quarters · filed 2026-03-05 | -$1.00K derived: sum of 3 quarters · filed 2026-03-05 | -$7.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $34.00K derived: sum of 2 quarters · filed 2026-03-05 | $28.00K derived: sum of 3 quarters · filed 2026-03-05 | $41.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $29.00K derived: sum of 2 quarters · filed 2024-11-06 | $42.00K 10-Q · filed 2024-11-06 | -$17.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $7.00K 10-Q · filed 2024-08-07 | -$52.00K derived: sum of 3 quarters · filed 2025-02-27 | -$107.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-08 | -$46.00K derived: sum of 2 quarters · filed 2025-02-27 | -$101.00K derived: sum of 3 quarters · filed 2025-02-27 | -$105.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$114.00K derived: sum of 2 quarters · filed 2025-02-27 | -$118.00K derived: sum of 3 quarters · filed 2025-02-27 | -$122.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$59.00K derived: sum of 2 quarters · filed 2023-11-08 | -$63.00K 10-Q · filed 2023-11-08 | $94.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$8.00K 10-Q · filed 2023-08-07 | $149.00K derived: sum of 3 quarters · filed 2023-08-07 | $144.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-09 | $153.00K derived: sum of 2 quarters · filed 2023-05-09 | $148.00K derived: sum of 3 quarters · filed 2023-05-09 | $143.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $152.00K derived: sum of 2 quarters · filed 2023-03-27 | $147.00K derived: sum of 3 quarters · filed 2023-03-27 | $139.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$10.00K derived: sum of 2 quarters · filed 2022-11-10 | -$18.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$13.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | -$8.00K 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $38.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |